Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study. - Terpos, Evangelos; Repousis, Panagiotis; Lalayanni, Chrysavgi; Hatjiharissi, Evdoxia; Assimakopoulou, Theodora; Vassilopoulos, Georgios; Pouli, Anastasia; Spanoudakis, Emmanouil; Michalis, Eurydiki; Pangalis, Gerassimos; Ntanasis-Stathopoulos, Ioannis; Poziopoulos, Christos; et al. (Journal of Clinical Medicine, 2021)